MENU
+Compare
LEXX
Stock ticker: NASDAQ
AS OF
Jun 5 closing price
Price
$0.99
Change
+$0.03 (+3.12%)
Capitalization
19.36M

LEXX Lexaria Bioscience Corp Forecast, Technical & Fundamental Analysis

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery... Show more

LEXX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for LEXX with price predictions
Jun 05, 2025

LEXX's RSI Oscillator ascending out of oversold territory

The RSI Oscillator for LEXX moved out of oversold territory on May 23, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 31 similar instances when the indicator left oversold territory. In of the 31 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

The Momentum Indicator moved above the 0 level on June 05, 2025. You may want to consider a long position or call options on LEXX as a result. In of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for LEXX just turned positive on May 23, 2025. Looking at past instances where LEXX's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where LEXX advanced for three days, in of 262 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LEXX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for LEXX entered a downward trend on June 05, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.630) is normal, around the industry mean (16.332). P/E Ratio (0.000) is within average values for comparable stocks, (59.787). LEXX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.227). Dividend Yield (0.000) settles around the average of (0.040) among similar stocks. P/S Ratio (29.070) is also within normal values, averaging (263.647).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. LEXX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LEXX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
LEXX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

LEXX is expected to report earnings to fall 5.03% to -15 cents per share on July 18

Lexaria Bioscience Corp LEXX Stock Earnings Reports
Q2'25
Est.
$-0.16
Q1'25
Est.
$-0.17
Q4'24
Missed
by $0.08
Q3'24
Missed
by $0.02
Q2'24
Est.
$-0.13
The last earnings report on April 15 showed earnings per share of -16 cents, beating the estimate of -17 cents. With 37.06K shares outstanding, the current market capitalization sits at 19.36M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
740 McCurdy Road
Phone
+1 250 765-6424
Employees
5
Web
https://www.lexariabioscience.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
STT96.480.48
+0.50%
State Street Corp
TILE20.08-0.05
-0.25%
Interface
VAC65.02-0.52
-0.79%
MARRIOTT VACATIONS WORLDWIDE Corp
AMS2.36-0.02
-0.82%
American Shared Hospital Services
MASS6.68-0.21
-3.12%
908 Devices

LEXX and Stocks

Correlation & Price change

A.I.dvisor tells us that LEXX and VERV have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LEXX and VERV's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LEXX
1D Price
Change %
LEXX100%
+3.03%
VERV - LEXX
30%
Poorly correlated
+8.22%
PDSB - LEXX
30%
Poorly correlated
-4.85%
MIST - LEXX
28%
Poorly correlated
+4.85%
STRO - LEXX
27%
Poorly correlated
-9.37%
BTAI - LEXX
27%
Poorly correlated
N/A
More